ARCHIVES

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

This article is from The Cancer Letter archive.

Vol. 28 No. 32 | September 6, 2002

Download PDF Visit The Full Archive

Related Articles

‘Helping Smokers Quit’ Program Launched By NCI, Pharmacist Group

June 27, 1986

In Brief: BRCA 2 Gene sequence Published; CALGB To Mark 40th Anniversary

March 8, 1996

Agencies Plan Better Reporting Of Adverse Events In Trials.

February 4, 2000

NIH Eyes FCRC For Intramural Space As Contract Recompetition Planning Nears

May 23, 1980

NIH Consensus Panel Calls for Large Randomized Trials of Hepatitis B Therapies.

October 31, 2008

Cancer Control Contract Negotiations To Start Soon; Two Weaknesses Occur In Many Proposals

March 7, 1975